Antibodies and Proteins developed with new and advantageous functions and properties are known as engineering of protein and antibody. Protein engineering in specific can be defined as a process of developing valuable proteins and modification of antibodies to increase similarity or specificity is called as antibody engineering.
Antibody and protein engineering are used in applications such as, inflammatory disorders new therapeutic for treatment of diseases, protein purification, diagnostic and autoimmune. There are two approaches used for designing new antibodies and proteins which are directed evolution and the second is rational designing.
Antibodies occupied a huge market share of approximately around USD 30 billion in 2014 and the market shows huge signs of growth for the next five years.
The market for antibody engineering is changing quickly due to novel technologies. Moreover, protein engineering offers flexibility in engineering and designing new and desirable antibodies is expected to be the major factor driving the growth of the market. In future the market has huge opportunities from rising prevalence of diseases such as cancer and increasing health care concerns.
Beryllium, ProSci Incorporated, Precision Antibody, Fusion Antibodies, BioXcell, GenTarget Inc, Imagin AB, covalab, and IBL international are some of the major players participating in the market.This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product type and distribution channels.
Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-214